During the past decade, Berliner Zentrum Reise- und Tropenmedizin conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Berliner Zentrum Reise- und Tropenmedizin" are "Japanese Encephalitis" (3 trials), "Clostridium Difficile" (1 trials) and "Encephalitis" (1 trials). Many other conditions were trialed in "Berliner Zentrum Reise- und Tropenmedizin" in a lesser frequency.

Most popular intervention types in "Berliner Zentrum Reise- und Tropenmedizin" are "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "IC51" (3 trials), "Japanese Encephalitis purified inactivated vaccine" (1 trials), "Placebo" (1 trials) and "VLA84" (1 trials). Other intervention names were less common.

The vast majority of trials in "Berliner Zentrum Reise- und Tropenmedizin" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Berliner Zentrum Reise- und Tropenmedizin". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Berliner Zentrum Reise- und Tropenmedizin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Berliner Zentrum Reise- und Tropenmedizin, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".